JAMA ophthalmology۲۰۲۶کارآزمایی بالینی تصادفینمایه شده در PubMed
Christine N Kay, Leonide Saad, Gabrielle DeBartolomeo, Neil Bressler, Stephen H Tsang, Kimberly Stepien, Paul Bernstein, Byron L Lam, Ilyas Washington, Michael B Gorin, TEASE-1 Study Group
چکیده
Stargardt disease (STGD) is the most common macular dystrophy, resulting in profound loss of vision. There is no approved treatment. To evaluate the safety and effects of oral gildeuretinol acetate on the growth of retinal atrophic lesions in individuals with STGD. TEASE-1 was a 2-year,…
متن کامل چکیده در سایت ناشر در دسترس است.
DOI: 10.1001/jamaophthalmol.2026.3662